Translational Advances in Gynecologic Cancers 1st Edition
Translational Advances in Gynecologic Cancers straddles the bench and bed divide by highlighting important and interesting research that is translatable to the clinic. The contents of this book cover the entire spectrum, from promising laboratory based research, to clinical trial efforts. Further, new therapeutic indications based upon randomized phase III trials are also included.
Clinicians will learn about lab-based science that is about to enter the clinic, along with the rationale behind translational endpoints in trials. Researchers will be able to identify and understand the clinical needs of patients with these types of tumors to improve their research focus.
- Provides a comprehensive description of all evolving translational gynecologic cancer research for clinicians
- Identifies knowledge gaps to inform the next research direction
- Ties together clinical research and patient needs to help both the researcher and clinician
- Addresses genomics, new target therapies, novel tools, and more for ovarian, endometrial, and cervical cancer
About the Author
Dr. Michael Birrer is a Professor of Medicine at Harvard Medical School, the Director of Medical Gynecologic Oncology, Gynecologic Oncology Research Program, and the Gellete Center for Gynecologic Oncology at Massachusetts General Hospital (MGH) in Boston, Massachusetts. He is also a practicing physician at MGH.
Read more about: Michael Birrer, Lorenzo Ceppi
There are no reviews yet.